• 1
    Kappesser J, Williams AC. Pain estimation: asking the right questions. Pain 2010; 148: 1847.
  • 2
    Visentin M, Zanolin E, Trentin L, et al. Prevalence and treatment of pain in adults admitted to Italian hospitals. European Journal of Pain 2005; 9: 617.
  • 3
    Sawyer J, Haslam L, Daines P, Stilos K. Pain prevalence study in a large Canadian teaching hospital. Round 2: lessons learned? Pain Management and Nursing 2010; 11: 4555.
  • 4
    Reid KJ, Harker J, Bala MM, et al. Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact. Current Medical Research and Opinion 2011; 27: 44962.
  • 5
    Reitsma ML, Tranmer JE, Buchanan DM, Vandenkerkhof EG. The prevalence of chronic pain and pain-related interference in the Canadian population from 1994 to 2008. Chronic Diseases in Canada 2011; 31: 15764.
  • 6
    Barden J. Defining the importance of change in clinical trials in acute pain. In: McQuay HJ, Kalso E, Moore RA, eds. Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008; 17584.
  • 7
    Anon. KISS Principle, 2011. (accessed 10/11/12).
  • 8
    Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimetres? Pain 1997; 72: 957.
  • 9
    Mhuircheartaigh RJ, Moore RA, McQuay HJ. Analysis of individual patient data from clinical trials: epidural morphine for postoperative pain. British Journal Anaesthesia 2009; 103: 87481.
  • 10
    Gerbershagen HJ, Rothaug J, Kalkman CJ, Meissner W. Determination of moderate-to-severe postoperative pain on the numeric rating scale: a cut-off point analysis applying four different methods. British Journal Anaesthesia 2011; 107: 61926.
  • 11
    Aldington DJ, McQuay HJ, Moore RA. End-to-end military pain management. Philosophical Transaction of the Royal Society of London B Biological Sciences 2011; 366: 26875.
  • 12
    Brown KE, Swift I, Spark MJ. Pain severity cut-points and analgesic use by community-dwelling people for chronic pain. Journal of Pharmacy Practice and Research 2012; 42: 1969.
  • 13
    Englbrecht M, Tarner IH, van der Heijde DM, et al. Measuring pain and efficacy of pain treatment in inflammatory arthritis: a systematic literature review. Journal of Rheumatolology Supplement 2012; 90: 310.
  • 14
    Lemeshow AR, Blum RE, Berlin JA, et al. Searching one or two databases was insufficient for meta-analysis of observational studies. Journal of Clinical Epidemiology 2005; 58: 86773.
  • 15
    Ruppen W, Derry S, McQuay H, Moore RA. Incidence of epidural hematoma, infection, and neurologic injury in obstetric patients with epidural analgesia/anesthesia. Anesthesiology 2006; 105: 3949.
  • 16
    Park CL, Roberts DE, Aldington DJ, Moore RA. Prehospital analgesia: systematic review of evidence. Journal of the Royal Army Medical Corps 2010; 156 (4 Suppl. 1): 295300.
  • 17
    O'Brien EM, Staud RM, Hassinger AD, et al. Patient-centered perspective on treatment outcomes in chronic pain. Pain Medicine 2010; 11: 615.
  • 18
    Brown JL, Edwards PS, Atchison JW, et al. Defining patient-centered, multidimensional success criteria for treatment of chronic spine pain. Pain Medicine 2008; 9: 85162.
  • 19
    Stutts LA, Robinson ME, McCulloch RC, et al. Patient-centered outcome criteria for successful treatment of facial pain and fibromyalgia. Journal of Orofacial Pain 2009; 23: 4753.
  • 20
    Thorne FM, Morley S. Prospective judgments of acceptable outcomes for pain, interference and activity: Patient-determined outcome criteria. Pain 2009; 144: 2629.
  • 21
    Lipton RB, Hamelsky SW, Dayno JM. What do patients with migraine want from acute migraine treatment? Headache 2002; 42 (Suppl. 1): 39.
  • 22
    Farrar JT, Portenoy RK, Berlin JA, et al. Defining the clinically important difference in pain outcome measures. Pain 2000; 88: 28794.
  • 23
    Lee JS, Hobden E, Stiell IG, Wells GA. Clinically important change in the visual analog scale after adequate pain control. Academic Emergency Medicine 2003; 10: 112830.
  • 24
    Salaffi F, Stancati A, Silvestri CA, et al. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. European Journal of Pain 2004; 8: 28391.
  • 25
    Mease PJ, Spaeth M, Clauw DJ, et al. Estimation of minimum clinically important difference for pain in fibromyalgia. Arthritis Care and Research (Hoboken) 2011; 63: 8216.
  • 26
    Farrar JT, Pritchett YL, Robinson M, et al. The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders. Journal of Pain 2010; 11: 10918.
  • 27
    Wells GA, Tugwell P, Kraag GR, et al. Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. Journal of Rheumatology 1993; 20: 55760.
  • 28
    Straube S, Derry S, Moore RA, et al. Pregabalin in fibromyalgia–responder analysis from individual patient data. BMC Musculoskeletal Disorders 2010; 11: 150.
  • 29
    Jensen MP, Schnitzer TJ, Wang H, et al. Sensitivity of single-domain versus multiple-domain outcome measures to identify responders in chronic low-back pain: pooled analysis of 2 placebo-controlled trials of etoricoxib. Clinical Journal of Pain 2012; 28: 17.
  • 30
    Heiberg T, Kvien TK. Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority. Arthritis & Rheumatism 2002; 47: 3917.
  • 31
    Tubach F, Ravaud P, Baron G, et al. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Annals of the Rheumatic Diseases 2005; 64: 347.
  • 32
    Ornetti P, Dougados M, Paternotte S, et al. Validation of a numerical rating scale to assess functional impairment in hip and knee osteoarthritis: comparison with the WOMAC function scale. Annals of the Rheumatic Diseases 2011; 70: 7406.
  • 33
    Jadad AR, Carroll D, Glynn CJ, et al. Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia. Lancet 1992; 339: 136771.
  • 34
    Walker JS, Sheather-Reid RB, Carmody JJ, et al. Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of “responders” and “nonresponders”. Arthritis and Rheumatism 1997; 40: 194454.
  • 35
    Crofford LJ, Mease PJ, Simpson SL, et al. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain 2008; 136: 41931.
  • 36
    Skljarevski V, Zhang S, Chappell AS, et al. Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study. Pain Medicine 2010; 11: 64857.
  • 37
    Bingham CO, Smugar SS, Wang H, Tershakovec AM. Early response to COX-2 inhibitors as a predictor of overall response in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib and placebo. Rheumatology (Oxford) 2009; 48: 11227.
  • 38
    Bellamy N, Bell MJ, Pericak D, et al. BLISS index for analyzing knee osteoarthritis trials data. Journal of Clinical Epidemiology 2007; 60: 12432.
  • 39
    Moore RA, Moore OA, Derry S, et al. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases 2010; 69: 3749.
  • 40
    McQuay HJ, Bullingham RE, Moore RA, et al. Some patients don't need analgesics after surgery. Journal of the Royal Society of Medicine 1982; 75: 7058.
  • 41
    Moore RA, Mhuircheartaigh RJ, Derry S, McQuay HJ. Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion. European Journal of Anaesthesiology 2011; 28: 42732.
  • 42
    Moore RA, Straube S, Paine J, et al. Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction. Pain 2011; 152: 9829.
  • 43
    Moore RA, Derry S, McQuay HJ, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults. Cochrane Database of Systematic Reviews 2011; 9: CD008659.
  • 44
    Peloso PM, Gammaitoni A, Smugar SS, et al. Longitudinal numbers-needed-to-treat (NNT) for achieving various levels of analgesic response and improvement with etoricoxib, naproxen, and placebo in ankylosing spondylitis. BMC Musculoskeletal Disorders 2011; 12: 165.
  • 45
    Moore RA, Smugar SS, Wang H, et al. Numbers-needed-to-treat analyses – do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials. Pain 2010; 151: 5927.
  • 46
    Derry CJ, Derry S, Moore RA. Sumatriptan (oral route of administration) for acute migraine attacks in adults. Cochrane Database of Systematic Review 2012; 2: CD008615.
  • 47
    Moore RA, Derry S, Aldington D, et al. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2012; 12: CD008242.
  • 48
    Strassels SA, McNicol E, Wagner AK, et al. Persistent postoperative pain, health-related quality of life, and functioning 1 month after hospital discharge. Acute Pain 2004; 6: 95104.
  • 49
    Wu CL, Naqibuddin M, Rowlingson AJ, et al. Theeffect of pain on health-related quality of life in theimmediate postoperative period. Anesthesia and Analgesia 2003; 97: 107885.
  • 50
    Pavlin DJ, Chen C, Penaloza DA, Buckley FP. A survey of pain and other symptoms that affect the recovery process after discharge from an ambulatory surgery unit. Journal of Clinical Anesthesia 2004; 16: 2006.
  • 51
    Wylde V, Rooker J, Halliday L, Blom A. Acute postoperative pain at rest after hip and knee arthroplasty: Severity, sensory qualities and impact on sleep. Orthopaedics and Traumatology, Surgery and Research 2011; 97: 13944.
  • 52
    Liu SS, Wu CL. The effect of analgesic technique on postoperative patient-reported outcomes including analgesia: a systematic review. Anesthesia and Analgesia 2007; 105: 789808.
  • 53
    Bennett RM, Schein J, Kosinski MR, et al. Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis and Rheumatism 2005; 53: 51927.
  • 54
    Dahlöf C, Loder E, Diamond M, et al. The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health and Quality of Life Outcomes 2007; 5: 56.
  • 55
    Schein JR, Kosinski MR, Janagap-Benson C, et al. Functionality and health-status benefits associated with reduction of osteoarthritis pain. Current Medical Research and Opinion 2008; 24: 125565.
  • 56
    Kosinski M, Janagap C, Gajria K, et al. Pain relief and pain-related sleep disturbance with extended-release tramadol in patients with osteoarthritis. Current Medical Research and Opinion 2007; 23: 161526.
  • 57
    Barthel HR, Peniston JH, Clark MB, et al. Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis. Arthritis Research and Therapy 2010; 12: R7.
  • 58
    Hoffman DL, Sadosky A, Dukes EM, Alvir J. How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy? Pain 2010; 149: 194201.
  • 59
    Moore RA, Straube S, Paine J, et al. Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain 2010; 149: 3604.
  • 60
    Straube S, Moore RA, Paine J, et al. Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response. BMC Musculoskeletal Disorders 2011; 12: 125.
  • 61
    Dworkin RH, Jensen MP, Gould E, et al. Treatment satisfaction in osteoarthritis and chronic low back pain: the role of pain, physical and emotional functioning, sleep, and adverse events. Journal of Pain 2011; 12: 41624.
  • 62
    vanSeventer R, Serpell M, Bach FW, et al. Relationships between changes in pain severity and other patient-reported outcomes: an analysis in patients with posttraumatic peripheral neuropathic pain. Health and Quality of Life Outcomes 2011; 9: 17.
  • 63
    Arnold LM, Wang F, Ahl J, et al. Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial. Arthritis Research and Therapy 2011; 13: R86.
  • 64
    Ikenberg R, Hertel N, Moore RA, et al. Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine. Journal of Medical Economics 2012; 15: 72436.
  • 65
    Deshpande MA, Holden RR, Gilron I. The impact of therapy on quality of life and mood in neuropathic pain: what is the effect of pain reduction? Anesthesia and Analgesia 2006; 102: 14739.
  • 66
    Kosinski MR, Schein JR, Vallow SM, et al. An observational study of health-related quality of life and pain outcomes in chronic low back pain patients treated with fentanyl transdermal system. Current Medical Research and Opinion 2005; 21: 84962.
  • 67
    Gülfe A, Kristensen LE, Saxne T, et al. Utility-based outcomes made easy: the number needed per quality-adjusted life year gained. An observational cohort study of tumor necrosis factor blockade in inflammatory arthritis from Southern Sweden. Arthritis Care and Research (Hoboken) 2010; 62: 1399406.
  • 68
    Moore RA, Eccleston C, Derry S, et al. “Evidence” in chronic pain – establishing best practice in the reporting of systematic reviews. Pain 2010; 150: 3869.
  • 69
    Moore RA, Straube S, Eccleston C, et al. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain 2012; 153: 2658.
  • 70
    Kumar K, Taylor RS, Jacques L, et al. The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery 2008; 63: 76270.
  • 71
    Räsänen P, Roine E, Sintonen H, et al. Use of quality-adjusted life years for the estimation of effectiveness of health care: a systematic literature review. International Journal of Technology Assessment in Health Care 2006; 22: 23541.
  • 72
    Moskovitz BL, Benson CJ, Patel AA, et al. Analgesic treatment for moderate-to-severe acute pain in the United States: patients' perspectives in the Physicians Partnering Against Pain (P3) survey. Journal of Opioid Management 2011; 7: 27786.
  • 73
    Sinatra R. Causes and consequences of inadequate management of acute pain. Pain Medicine 2010; 11: 185971.
  • 74
    Powell AE, Davies HT, Bannister J, Macrae WA. Challenge of improving postoperative pain management: case studies of three acute pain services in the UK National Health Service. British Journal of Anaesthesia 2009; 102: 82431.
  • 75
    National Collaborating Centre for Chronic Conditions. Osteoarthritis: National Clinical Guideline for Care and Management in Adults. London: Royal College of Physicians, 2008.
  • 76
    National Institute for Health and Clinical Excellence. (2010). Neuropathic Pain: The Pharmacological Management of Neuropathic Pain in Adults in Non-Specialist Settings. London: National Institute for Health and Clinical Excellence. Available from: (accessed 01/12/2012).
  • 77
    Towheed T, Maxwell L, Judd M, et al. Acetaminophen for osteoarthritis. Cochrane Database of Systematic Reviews 2006; 1: CD004257.
  • 78
    Eccleston C, Palermo TM, Fisher E, Law E. Psychological interventions for parents of children and adolescents with chronic illness. Cochrane Database of Systematic Reviews 2012; 8: CD009660.